ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan

Yuhei Hatakenaka,1,2 Elisabeth Fernell,2 Masahiko Sakaguchi,3 Hitoshi Ninomiya,3 Ichiro Fukunaga,1 Christopher Gillberg2 1Kochi Gillberg Neuropsychiatry Centre, Kochi Prefectural Medical and Welfare Centre, Kochi, Japan; 2Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenbur...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hatakenaka Y, Fernell E, Sakaguchi M, Ninomiya H, Fukunaga I, Gillberg C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/a10a59332f7240d2b100503b61c3b458
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a10a59332f7240d2b100503b61c3b458
record_format dspace
spelling oai:doaj.org-article:a10a59332f7240d2b100503b61c3b4582021-12-02T04:03:54ZESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan1178-2021https://doaj.org/article/a10a59332f7240d2b100503b61c3b4582016-07-01T00:00:00Zhttps://www.dovepress.com/essence-q-ndash-a-first-clinical-validation-study-of-a-new-screening-q-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Yuhei Hatakenaka,1,2 Elisabeth Fernell,2 Masahiko Sakaguchi,3 Hitoshi Ninomiya,3 Ichiro Fukunaga,1 Christopher Gillberg2 1Kochi Gillberg Neuropsychiatry Centre, Kochi Prefectural Medical and Welfare Centre, Kochi, Japan; 2Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 3Integrated Centre for Advanced Medical Technologies, Kochi University Medical School, Kochi, Japan Background: Early identification of autism spectrum disorder, intellectual developmental disorder, attention-deficit/hyperactivity disorder, and other neurodevelopmental disorders/problems is crucial, yet diagnosis is often delayed for years under the often misguided “wait-and-see” paradigm. The early symptomatic syndromes eliciting neurodevelopmental clinical examinations-questionnaire (ESSENCE-Q) is a brief (12-item) screening questionnaire developed specifically for the purpose of speeding up the identification process of a wide variety of neurodevelopmental problems. The aims were to 1) estimate the reliability of the ESSENCE-Q, 2) evaluate the clinical cutoff levels suggested by the author of the ESSENCE-Q, and 3) propose optimal cutoff levels based on receiver operating characteristic analysis.Methods: The ESSENCE-Q was used for 1 year by a psychiatrist in Kochi, Japan, assessing children under the age of 6 years referred for developmental problems. The children were also clinically assessed with regard to whether or not they met criteria for a developmental disorder (diagnosis positive and diagnosis negative groups). We contrasted the results of the ESSENCE-Q and those of clinical diagnostic assessments in 130 cases.Results: Cronbach’s alpha was 0.82, sensitivity was 0.94 (95% confidence interval [CI]: [0.88, 0.98]), and specificity 0.53 (95% CI: [0.28, 0.77]), which are reasonable psychometrics for a first-step screening tool. Based on receiver operating characteristic analysis, we recommended an optimal cutoff level of yes ≥2 or maybe/a little ≥3 on the ESSENCE-Q (0.87 (95% CI: [0.79, 0.92]) sensitivity and 0.77 (95% CI: [0.50, 0.93]) specificity).Conclusion and implication: The ESSENCE-Q can be a good instrument for use as a screening tool for aiding in the process of early identification of neurodevelopmental disorders in clinical settings. To establish the broader validity and reliability of the ESSENCE-Q, case–control studies and general population studies of children in different age groups are needed. Keywords: ESSENCE, ESSENCE-Q, cutoff levels, receiver operating characteristic analysisHatakenaka YFernell ESakaguchi MNinomiya HFukunaga IGillberg CDove Medical PressarticleESSENCEESSENCE-Qcutoff levelsReceiver Operating Characteristic (ROC) analysisNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 1739-1746 (2016)
institution DOAJ
collection DOAJ
language EN
topic ESSENCE
ESSENCE-Q
cutoff levels
Receiver Operating Characteristic (ROC) analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle ESSENCE
ESSENCE-Q
cutoff levels
Receiver Operating Characteristic (ROC) analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hatakenaka Y
Fernell E
Sakaguchi M
Ninomiya H
Fukunaga I
Gillberg C
ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
description Yuhei Hatakenaka,1,2 Elisabeth Fernell,2 Masahiko Sakaguchi,3 Hitoshi Ninomiya,3 Ichiro Fukunaga,1 Christopher Gillberg2 1Kochi Gillberg Neuropsychiatry Centre, Kochi Prefectural Medical and Welfare Centre, Kochi, Japan; 2Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 3Integrated Centre for Advanced Medical Technologies, Kochi University Medical School, Kochi, Japan Background: Early identification of autism spectrum disorder, intellectual developmental disorder, attention-deficit/hyperactivity disorder, and other neurodevelopmental disorders/problems is crucial, yet diagnosis is often delayed for years under the often misguided “wait-and-see” paradigm. The early symptomatic syndromes eliciting neurodevelopmental clinical examinations-questionnaire (ESSENCE-Q) is a brief (12-item) screening questionnaire developed specifically for the purpose of speeding up the identification process of a wide variety of neurodevelopmental problems. The aims were to 1) estimate the reliability of the ESSENCE-Q, 2) evaluate the clinical cutoff levels suggested by the author of the ESSENCE-Q, and 3) propose optimal cutoff levels based on receiver operating characteristic analysis.Methods: The ESSENCE-Q was used for 1 year by a psychiatrist in Kochi, Japan, assessing children under the age of 6 years referred for developmental problems. The children were also clinically assessed with regard to whether or not they met criteria for a developmental disorder (diagnosis positive and diagnosis negative groups). We contrasted the results of the ESSENCE-Q and those of clinical diagnostic assessments in 130 cases.Results: Cronbach’s alpha was 0.82, sensitivity was 0.94 (95% confidence interval [CI]: [0.88, 0.98]), and specificity 0.53 (95% CI: [0.28, 0.77]), which are reasonable psychometrics for a first-step screening tool. Based on receiver operating characteristic analysis, we recommended an optimal cutoff level of yes ≥2 or maybe/a little ≥3 on the ESSENCE-Q (0.87 (95% CI: [0.79, 0.92]) sensitivity and 0.77 (95% CI: [0.50, 0.93]) specificity).Conclusion and implication: The ESSENCE-Q can be a good instrument for use as a screening tool for aiding in the process of early identification of neurodevelopmental disorders in clinical settings. To establish the broader validity and reliability of the ESSENCE-Q, case–control studies and general population studies of children in different age groups are needed. Keywords: ESSENCE, ESSENCE-Q, cutoff levels, receiver operating characteristic analysis
format article
author Hatakenaka Y
Fernell E
Sakaguchi M
Ninomiya H
Fukunaga I
Gillberg C
author_facet Hatakenaka Y
Fernell E
Sakaguchi M
Ninomiya H
Fukunaga I
Gillberg C
author_sort Hatakenaka Y
title ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
title_short ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
title_full ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
title_fullStr ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
title_full_unstemmed ESSENCE-Q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south Japan
title_sort essence-q – a first clinical validation study of a new screening questionnaire for young children with suspected neurodevelopmental problems in south japan
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/a10a59332f7240d2b100503b61c3b458
work_keys_str_mv AT hatakenakay essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
AT fernelle essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
AT sakaguchim essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
AT ninomiyah essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
AT fukunagai essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
AT gillbergc essenceqndashafirstclinicalvalidationstudyofanewscreeningquestionnaireforyoungchildrenwithsuspectedneurodevelopmentalproblemsinsouthjapan
_version_ 1718401448925986816